期刊论文详细信息
Frontiers in Medicine | |
Pharmacokinetics and Dosimetry Studies for Optimization of Pretargeted Radioimmunotherapy in CEA-Expressing Advanced Lung Cancer Patients | |
Caroline Bodet-Milin1  | |
关键词: lung cancer; radioimmunotherapy; pretargeting; pharmacokinetics; scintigraphy; SPECT; SPECT/CT; dosimetry; | |
DOI : 10.3389/fmed.2015.00084 | |
学科分类:医学(综合) | |
来源: Frontiers | |
【 摘 要 】
ObjectivesA phase I pretargeted radioimmunotherapy trial (EudractCT 200800603096) was designed in patients with metastatic lung cancer expressing carcinoembryonic antigen (CEA) to optimize bispecific antibody and labeled peptide doses, as well as the delay between their injections.
【 授权许可】
CC BY
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO201901227387908ZK.pdf | 3140KB | download |